SFC

Sommaire


CARDIOLOGIE PÉDIATRIQUE

CARDIO-ONCOLOGIE

  • Cardiovascular Disease Risk Among Cancer Survivors: The Atherosclerosis Risk In Communities (ARIC) Study. Journal of the American College of Cardiology, 80(1), 22–32. | Lire l'article SCIENCE DIRECT
  • Advances in Multimodality Imaging in Cardio-Oncology. J Am Coll Cardiol. 2022 Oct, 80 (16) 1560–1578. | Lire l'article SCIENCE DIRECT

CORONAIRES ET INTERVENTIONNEL

  • Does Capturing Debris during TAVR Prevent Strokes? | Lire l'article NEJM
  • Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week | Lire l'article ACADEMIC

HTA

  • Intensive Blood Pressure Lowering in Patients With Malignant Left Ventricular Hypertrophy | Lire l'article JACC
  • Longer-Term All-Cause and Cardiovascular Mortality With Intensive Blood Pressure Control: A Secondary Analysis of a Randomized Clinical Trial | Lire l'article JAMA NETWORK

IMAGERIE CARDIOVASCULAIRE

  • Should CMR Be Performed for Every Patient With Frequent Premature Ventricular Contractions? | Lire l'article JACC
  • Coronary artery calcium scoring for cardiovascular risk stratification: more pitfalls than advantages? | Lire l'article ACADEMIC

INSUFFISANCE CARDIAQUE – CARDIOMYOPATHIES

RISQUE CARDIOVASCULAIRE

  • Influence of Age on the Diagnosis of Myocardial Infarction | Lire l'article AHA JOURNALS
  • Rivaroxaban and aspirin vs. aspirin alone in Asian compared with non-Asian patients with chronic coronary artery disease or peripheral arterial disease: the COMPASS trial | Lire l'article ACADEMIC
  • Galectin 3 enhances platelet aggregation and thrombosis via Dectin-1 activation: a translational study | Lire l'article ACADEMIC
  • CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical research | Lire l'article ACADEMIC

RYTHMOLOGIE

  • Association of Sodium-Glucose Cotransporter-2 Inhibitors With Incident Atrial Fibrillation in Older Adults With Type 2 Diabetes | Lire l'article JAMA NETWORK
  • Incidence and Predictors of Early Death in Patients Undergoing Percutaneous Left Atrial Appendage Closure | Lire l'article JACC
  • Cardiac Magnetic Resonance in the Evaluation of Patients With Frequent Premature Ventricular Complexes | Lire l'article JACC
  • Programmed Ventricular Stimulation as an Additional Primary Prevention Risk Stratification Tool in Arrhythmogenic Right Ventricular Cardiomyopathy: A Multinational Study | Lire l'article AHA JOURNALS
  • The Case for Home AED in Children, Adolescents, and Young Adults Not Meeting Criteria for ICD | Lire l'article JACC
  • Efficacy and Safety of an Extravascular Implantable Cardioverter–Defibrillator | Lire l'article NEJM
  • Device-related complications in subcutaneous versus transvenous ICD: a secondary analysis of the PRAETORIAN trial | Lire l'article ACADEMIC
  • Oral anticoagulants in patients with atrial fibrillation at low stroke risk: a multicentre observational study | Lire l'article ACADEMIC
  • Programmed Ventricular Stimulation as an Additional Primary Prevention Risk Stratification Tool in Arrhythmogenic Right Ventricular Cardiomyopathy: A Multinational Study | Lire l'article AHA JOURNALS
  • Efficacy and Safety of an Extravascular Implantable Cardioverter–Defibrillator | Lire l'article NEJM

USIC

  • Heart Failure Drug Treatment—Inertia, Titration, and Discontinuation: A Multinational Observational Study (EVOLUTION HF) | Lire l'article JACC

VALVULOPATHIES

COVID

  • Cardiovascular Drug Interactions With Nirmatrelvir/Ritonavir in Patients With COVID-19: JACC Review Topic of the Week | Lire l'article JACC
  • Protective Effect of Previous SARS-CoV-2 Infection against Omicron BA.4 and BA.5 Subvariants | Lire l'article NEJM
  • A Bivalent Omicron-Containing Booster Vaccine against Covid-19 | Lire l'article NEJM

LA FRANCE À L’HONNEUR

Nos suggestions d’actualités

Les actualités Cardio Online

La muvalaplin : nouvel inhibiteur de la lp(a) par voie orale

21 novembre 2024

Pas de supériorité d’un système d’aide à la décision pour optimiser les thérapies hypolipémiantes dans le post SCA

21 novembre 2024

Efficacité et sécurité d’emploi de l’obicetrapib, un nouvel inhibiteur de la CETP

21 novembre 2024

Zerlasiran, encore un nouvel antiLp(a) en développement

21 novembre 2024

L’edoxaban pour la prévention de thrombose valvulaire

20 novembre 2024

22/11/2024
Actualités SFC
Veille bibliographique

La SFC a lu pour vous : Veille bibliographique - 22/11/24

21/11/2024
Actualités Communautés
Newsletter

Newsletter de la SFHTA - Novembre 2024

21/11/2024
Actualités Congrès
Congrès

Impact environnemental de la cardiologie : Participez à notre enquête nationale !